Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | 19.7% | 18.1% | 17.3% | 14.8% | 16.8% | 17.1% | 18.5% | 19.4% | 20.3% | 19.4% | 17.5% | 18.7% | 19.7% | 21.0% | 22.2% | 23.0% | 25.7% | 29.0% | 26.7% | 30.0% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is 29.0%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Operating Income margin for IDEXX Laboratories, Inc. have been 28.5% over the past three years, and 28.7% over the past five years.
As of today, IDEXX Laboratories, Inc.'s Operating Income margin is 29.0%, which is higher than industry median of (28.2%). It indicates that IDEXX Laboratories, Inc.'s Operating Income margin is Good.